Success Metrics

Completion Rate
0%(0/1)
Active Trials
0(0%)
Terminated
1(50%)

Phase Distribution

Ph phase_3
2
100%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution2 total trials
Phase 3Large-scale testing
2(100.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

2

all time

Status Distribution
Terminated(1)
Other(1)

Detailed Status

Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
2
Active
0
Success Rate
0.0%
Most Advanced
Phase 3

Trials by Phase

Phase 32 (100.0%)

Trials by Status

terminated150%
unknown150%

Recent Activity

0 active trials
Showing 2 of 2
terminatedphase_3

Will Hydroxychloroquine Impede or Prevent COVID-19

NCT04341441
unknownphase_3

PROLIFIC ChemoprophylaxisTrial (COVID-19)

NCT04352933

Clinical Trials (2)

Showing 2 of 2 trials
NCT04341441Phase 3

Will Hydroxychloroquine Impede or Prevent COVID-19

Terminated
NCT04352933Phase 3

PROLIFIC ChemoprophylaxisTrial (COVID-19)

Unknown

All 2 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
2